LNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Locked nucleic acid (LNA) is a nucleic acid analogue containing one or more LNA nucleotide monomers with a bicyclic furanose unit locked in an RNA mimicking sugar conformation. LNA oligonucleotides display unprecedented hybridization affinity toward complementary single-stranded RNA and complementary single- or double-stranded DNA. Structural studies have shown that LNA oligonucleotides induce A-type (RNA-like) duplex conformations. The wide applicability of LNA oligonucleotides for gene silencing and their use for research and diagnostic purposes are documented in a number of recent reports, some of which are described herein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antisense oligonucleotides are an attractive therapeutic strategy because they can inhibit mRNA expression specifically [7, 8].”
From Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors (2014) · cites this paper as [8]
Citations
Cites
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Self-citationAn autonomous molecular computer for logical control of gene expression
Benenson, Y., Gil, B., Ben-Dor, U., Adar, R., & Shapiro, E. (2004) · Nature · doi:10.1038/nature02551 · Cited by 821
LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition
Singh, S. K., Koshkin, A. A., Wengel, J., & Nielsen, P. (1998) · Chemical Communications · doi:10.1039/a708608c · Cited by 768
Self-citationObika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
LNA: a versatile tool for therapeutics and genomics
Petersen, M., & Wengel, J. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00038-0 · Cited by 613
Self-citationObika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
Design of antisense oligonucleotides stabilized by locked nucleic acids
Kurreck, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1911 · Cited by 577
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Self-citation
Research works printed but not linked: 39
- Jepsen J. S., 2004, Curr. Opin. Drug Discovery Dev. 7, 188−194.
- Singh S. K., 1998, Chem. Commun. 4, 455−456.
- Koshkin A. A., 1998, Cytosine, Guanine, 5-Methylcytosine, Thymine and Uracil Bicyclonucleoside Monomers, Oligomerisation, and Unprecedented Nucleic Acid Recognition, Tetrahedron 54, 3607−3630.
- Wengel J., 1999, Acc. Chem. Res. 32, 301−310.
- McTigue P. M., 2004, Biochemistry 43, 5388−5405.
- Nielsen K. E., 2004, Bioconjugate Chem. 15, 449−457.
- Nielsen K. M. E., 2002, Chem.Eur. J., 8
- Nielsen J. T., 2003, Nucleic Acids Res. 31, 5858−5867.
- Wahlestedt C., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
- Kurreck J., 2002, Nucleic Acids Res. 30
- Frieden M., 2003, Nucleic Acids Res. 31, 6365−6372.
- Crinelli R., 2002, Nucleic Acids Res. 30, 2435−2443.
- Santoro S. W., 1997, Proc. Natl. Acad. Sci. U.S.A. 94
- Schubert S., 2003, DNAzymes with enhanced stability and activity, Nucleic Acids Res. 31, 5982−5992.
- Fahmy R. G., 2004, Nucleic Acids Res. 32, 2281−2285.
- Obika S., 2001, Nucleic Acids Res. Suppl., 145−146.
- Hansen J. B., 2003, Nucleosides, Nucleotides Nucleic Acids 22, 1607−1609.
- Elayadi A. N., 2002, Biochemistry 41, 9973−9981.
- Childs J. L., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
- Ittig D., 2004, Nucleic Acids Res. 32, 346−353.
- Grünweller A., 2003, Nucleic Acids Res. 31, 3185−3193.
- Braasch D. A., 2003, Biochemistry 42, 7967−7975.
- Schwarz D. S., 2003, Cell 115, 199−208.
- Arzumanov A., 2003, Oligonucleotides 13, 435−453.
- Buchini S., 2003, Curr. Opin. Chem. Biol. 7, 717−726.
- Obika S., 2000, Tetrahedron Lett., 41
- Obika S., 2001, Chem. 9, 1001−1011.
- Sun B. W., 2004, Biochemistry 43, 4160−4169.
- Goni J. R., 2004, Nucleic Acids Res. 32, 354−360.
- Hertoghs K. M., 2003, Nucleic Acids Res. 31, 5817−5830.
- Jacobsen N., 2002, Clin. Chem. 48, 657−660.
- Ørum H., 1999, Clin. Chem. 45
- Ugozzoli L. A., 2004, Anal. Biochem. 324, 143−152.
- Letertre C., 2003, Mol. Cell Probes 17, 307−311.
- Tolstrup N., 2003, Nucleic Acids Res. 31, 3758−3762.
- Silahtaroglu A. N., 2003, Mol. Cell Probes 17, 165−169.
- Sørensen M. D., 2003, Chem. Commun. 17, 2130−2131.
- Benenson Y., 2004, Nature 429, 423−429.
- Abbreviations LNA, locked nucleic acid
Cited by
Items 301–400 of 727
Functional Studies of microRNAs in Neural Stem Cells: Problems and Perspectives
Åkerblom, M., Sachdeva, R., & Jakobsson, J. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00014 · Cited by 31
“Recently, LNA (locked nucleic acid) modified oligonucleotides allow for even further stabilization of the miRNA/target duplex structure improving silencing and also making it possible to the use small oligonucleotides that enables targeting of entire miRNA-families (Vester and Wengel, 2004; Obad et al., 2011).”
Jin, Y., Andrade, J., & Wickstrom, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142574 · Cited by 28
“However, the lowered folding energy could be compensated by the LNA residues within anti-miR-17-5p, since LNA:RNA duplexes are highly stable [36].”
BackgroundEaston, A. E., Jensen, M. L., Wang, C., Hagedorn, P., Li, Y.-W., Weed, M. R., Meredith, J. E., Guss, V. L., Jones, K. M., Gill, M. B., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.027 · Cited by 28
Recognition of Chromosomal DNA inside Cells by Locked Nucleic Acids
Beane, R. L., Gabillet, S., Montaillier, C., Arar, K., & Corey, D. R. (2008) · Biochemistry · doi:10.1021/bi801930p · Cited by 28
DNA and RNA derivatives to optimize distribution and delivery
Wickstrom, E. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.012 · Cited by 28
“Elmen J, Thonberg H, Ljungberg K, Frieden M, Westergaard M, Xu Y, Wahren B, Liang Z, Orum H, Koch T, Wahlestedt C. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.”
BackgroundInfluentialGorle, S., & Priyakumar, U. D. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4016068 · Cited by 28
Conformationally restricted nucleotides as a probe of structure–function relationships in RNA
Julien, K. R., Sumita, M., Chen, P., Laird‐Offringa, I. A., & Hoogstraten, C. G. (2008) · RNA · doi:10.1261/rna.866408 · Cited by 28
“The properties and applications of LNAs and related molecules have been reviewed (Braasch and Corey 2001; Vester and Wengel 2004; Karkare and Bhatnagar 2006; Kaur et al. 2007).”
BackgroundOligonucleotide therapeutics and their chemical modification strategies for clinical applications
Kim, H., Kim, S., Lee, D., Lee, D., Yoon, J., & Lee, H. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00669-8 · Cited by 33
“…between the ribose 2 ′ oxygen and 4 ′ carbon, bridged nucleic acid (BNA) oligomers display restricted conformation of C3 ′ -endo sugar puker-ing, resulting in highly efficient complementary binding to the target RNA compared to the 2 ′ modified oligomers of the same length (Vester and Wengel 2004).”
Endogenous origin of endo-β-1,4-glucanase in common woodlouse Porcellio scaber (Crustacea, Isopoda)
Kostanjšek, R., Milatovič, M., & Štrus, J. (2010) · Journal of Comparative Physiology B · doi:10.1007/s00360-010-0485-7 · Cited by 28
“Sections were prehybridized in prehybridization buVer (IsHyb In Situ Hybridization (ISH) Kit, BioChain) for 3 h at 55°C and then hybridized overnight at 58°C in hybridization buVer (IsHyb In Situ Hybridization (ISH) Kit, BioChain) containing 10 nM of LNA probe ( Vester and Wengel 2004 ).”
MethodArtificial DNA and surface plasmon resonance
D’Agata, R., & Spoto, G. (2012) · Artificial DNA PNA & XNA · doi:10.4161/adna.21383 · Cited by 29
Enderlin, G., & Nielsen, P. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801081t · Cited by 27
FluorescenceIn SituHybridization for MicroRNA Detection in Archived Oral Cancer Tissues
Shi, Z., Johnson, J. J., & Stack, M. S. (2012) · Journal of Oncology · doi:10.1155/2012/903581 · Cited by 30
Jin, D.-J., Fang, Y., Li, Z., Chen, Z., & Xiang, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3638 · Cited by 31
Developments in Mirna Gene Signaling Pathways in Pancreatic Cancer
Vorvis, C., Κουτσιούμπα, Μ., & Iliopoulos, D. (2016) · Future Oncology · doi:10.2217/fon-2015-0050 · Cited by 28
TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans
Nies, V. J. M., Struik, D., Wolfs, M. G. M., Rensen, S. S., Szalowska, E., Unmehopa, U. A., Fluiter, K., van der Meer, T. P., Hajmousa, G., Buurman, W. A., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.214 · Cited by 29
Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma
Lu, M., Xu, X., Xi, B., Dai, Q., Li, C., Su, L., Zhou, X., Tang, M., Yao, Y., & Yang, J. (2018) · Genes · doi:10.3390/genes9010044 · Cited by 25
“[13] found that hsa-mir-375 [55] was up-regulated in PTC and MTC; hsa-mir-144 was up-regulated in PTC; hsa-mir-187 was up-regulated in PTC and FTC; and hsa-mir-221 [56,57] and hsa-mir-222 [56,58] were up-regulated in PTC, FTC, and ATC [55], which confirm the intimate association of our key drivers to thyroid cancer.”
BackgroundRole of LINC00152 in non-small cell lung cancer
Yu, H., & Li, S. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900312 · Cited by 27
“One of the major advances in ASO chemistry is the development of locked nucleic acid (LNA) (Vester and Wengel, 2004) that is synthesized using modified RNA nucleotides.”
BackgroundKunz, M., Brandl, M., Bhattacharya, A., Nobereit-Siegel, L., Ewe, A., Weirauch, U., Hering, D., Reinert, A., Kalwa, H., Guzman, J., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00728-w · Cited by 25
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1
Stoodley, J., Vallejo-Bedia, F., Seoane-Miraz, D., Debasa‐Mouce, M., Wood, M. J. A., & Varela, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032697 · Cited by 26
“Nucleic acids containing LNA subunits have been used as mixmers which contain several LNA subunits in random positions within an ASO; or as gapmers with several LNA subunits on both sides of the ASO [48,49].”
MethodIn-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Jehan, Z., Shahab Uddin, M. S., & Al-Kuraya, K. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661031 · Cited by 27
Synthetic genetic polymers: advances and applications
Ma, Q., Lee, D., Tan, Y. Q., Wong, G. B., & Gao, Z. (2016) · Polymer Chemistry · doi:10.1039/c6py01075j · Cited by 27
Analysis of microRNA functions
Remsburg, C. M., Konrad, K. D., Sampilo, N. F., & Song, J. L. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.10.005 · Cited by 30
MicroRNAs in diagnosis and therapeutics
Atri, C., Guerfali, F. Z., & Laouini, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00006-3 · Cited by 28
Freage, L., Jamal, D., Williams, N. B., & Mallikaratchy, P. R. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.016 · Cited by 24
“This constraint on the ribose moiety results in locked C30 endo hybridization that increases affinity toward its complementary base, resulting in enhancement of duplex stability.(23,24) The 20-OMe group (20-OMe RNA) is a naturally occurringmodification found in RNA that enhances affinity for RNA-DNA targets because of…”
BackgroundRole of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma
Soliman, A. M., Teoh, S. L., Mahakkanukrauh, P., & Das, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207539 · Cited by 26
Bioprobes-regulated precision biosensing of exosomes: From the nanovesicle surface to the inside
Peng, X., Qin, X., Qin, Y., Xiang, Y., Zhang, G., & Yang, F. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214538 · Cited by 25
XNAs: A Troubleshooter for Nucleic Acid Sensing
Mana, T., Bhattacharya, B., Lahiri, H., & Mukhopadhyay, R. (2022) · ACS Omega · doi:10.1021/acsomega.2c00581 · Cited by 24
Das, G., Harikrishna, S., & Gore, K. R. (2022) · The Chemical Record · doi:10.1002/tcr.202200174 · Cited by 32
Staedel, C., Varon, C., Nguyen, P. H., Vialet, B., Chambonnier, L., Rousseau, B., Soubeyran, I., Évrard, S., Couillaud, F., & Darfeuille, F. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.18 · Cited by 26
Azevedo, A. S., Almeida, C., Pereira, B., Madureira, P., Wengel, J., & Azevedo, N. F. (2015) · Biochemical Engineering Journal · doi:10.1016/j.bej.2015.04.024 · Cited by 24
Self-citationGustafson, K. S. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070076 · Cited by 24
“Locked nucleic acids (LNAs) are nucleic acid analogs that contain a 2 -O, 4 -C methylene bridge within the ribose ring that imparts a rigid conformational structure that enhances thermal stability and improves bp discrimination.(12,13) LNAs can be substituted into DNA oligonucleotides at selective sites to enhance hyb…”
BackgroundMethodMishra, S., Ghosh, S., & Mukhopadhyay, R. (2012) · Langmuir · doi:10.1021/la204026j · Cited by 24
sRNA‐FISH: versatile fluorescent in situ detection of small RNAs in plants
Huang, K., Baldrich, P., Meyers, B. C., & Caplan, J. L. (2018) · The Plant Journal · doi:10.1111/tpj.14210 · Cited by 25
“A major advancement has occurred with the advent of locked nucleic acid (LNA) oligonucleotide probes that have improved affinity, sensitivity and specificity (Vester and Wengel, 2004).”
BackgroundMethodInfluentialPendergraff, H. M., Schmidt, S., Vikeså, J., Weile, C., Øverup, C., Lindholm, M., & Koch, T. (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2019.0810 · Cited by 26
Novel Method for PIK3CA Mutation Analysis
Ang, D. C., O’Gara, R., Schilling, A., Beadling, C., Warrick, A., Troxell, M. L., & Corless, C. L. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.12.005 · Cited by 28
Biodistribution of 68 Ga-Labeled LNA–DNA Mixmer Antisense Oligonucleotides for Rat Chromogranin-A
Lendvai, G., Velikyan, I., Estrada, S., Eriksson, B. K., Långström, B., & Bergström, M. (2008) · Oligonucleotides · doi:10.1089/oli.2007.0104 · Cited by 24
“…affinity and specificity, LNA possesses improved mismatch discrimination, displays high stability, good aqueous solubility, low toxicity, and poor immunstimulation (Fluiter et al., 2003; Jepsen et al., 2004; Vester and Wengel, 2004), which makes it an obvious candidate for antisense gene silencing.”
Möhrle, B. P., Kumpf, M., & Gauglitz, G. (2005) · The Analyst · doi:10.1039/b507728a · Cited by 24
Bruylants, G., Boccongelli, M., Snoussi, K., & Bartik, K. (2009) · Biochemistry · doi:10.1021/bi900615z · Cited by 23
MiRNA-Based Therapeutics in Oncology, Realities, and Challenges
Bălăcescu, O., Visan, S., Baldasici, O., Balacescu, L., Vlad, C., & Achimaș-Cadariu, P. (2018) · Antisense Therapy · doi:10.5772/intechopen.81847 · Cited by 23
Koehler, R. N., Walsh, A., Moqueet, N., Currier, J. R., Eller, M. A., Eller, L. A., Wabwire‐Mangen, F., Michael, N. L., Robb, M., McCutchan, F. E., et al. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01265.x · Cited by 23
Screening the Structural Space of Bicyclo‐DNA: Synthesis and Thermal Melting Properties of bc4,3‐DNA
Stauffiger, A., & Leumann, C. J. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200801034 · Cited by 23
A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine
Andersen, V. L., Vinther, M., Kumar, R., Ries, A., Wengel, J., Nielsen, J. S., & Kjems, J. (2019) · Theranostics · doi:10.7150/thno.32060 · Cited by 27
“stable assembly of smaller and simpler structures [25,26].”
BackgroundSelf-citationAzuma, Y., Yokobori, T., Mogi, A., Yajima, T., Kosaka, T., Iijima, M., Shimizu, K., Shirabe, K., & Kuwano, H. (2020) · Surgery today (Print) · doi:10.1007/s00595-020-01976-x · Cited by 23
Detecting sRNAs by Northern Blotting
López-Gomollón, S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-083-6_3 · Cited by 23
Targeted Genome Modification via Triple Helix Formation
Ricciardi, A. S., McNeer, N. A., Anandalingam, K. K., Saltzman, W. M., & Glazer, P. M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0992-6_8 · Cited by 23
“This rigid conformation reduces barriers to binding by lowering the binding entropy [11].”
BackgroundDupouy, C., Clézio, I. L., Lavedan, P., Gornitzka, H., Escudier, J., & Vigroux, A. (2006) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200600593 · Cited by 23
Regulatory roles and therapeutic potential of microRNA in sarcoma
Lim, H. J., & Yang, J. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.001 · Cited by 22
Kim, J., Lee, E. H., Kang, Y. Y., & Mok, H. (2015) · Chemical Communications · doi:10.1039/c5cc02052b · Cited by 22
Selection of a novel DNA thioaptamer against HER2 structure
Hu, Y., Duan, J., Cao, B., Zhang, L., Lu, X., Wang, F., Yao, F., Zhu, Z., Yuan, W., Wang, C., et al. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1292-0 · Cited by 22
Kumar, P., Truong, L., Baker, Y. R., El-Sagheer, A. H., & Brown, T. (2018) · ACS Omega · doi:10.1021/acsomega.8b01086 · Cited by 23
Komiya, K., Komori, M., Noda, C., Kobayashi, S., Yoshimura, T., & Yamamura, M. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00521h · Cited by 22
Sekiguchi, M., Obika, S., Harada, Y., Osaki, T., Roongjang, S., Mitsuoka, Y., Shibata, N., Masaki, M., & Imanishi, T. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo051187l · Cited by 22
Oligonucleotides: evolution and innovation
Mohammed, A. A., Shaer, D. A., & Musaimi, O. A. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03352-7 · Cited by 30
Lipid‐based nucleic acid therapeutics with in vivo efficacy
Sufian, M. A., & Ilies, M. A. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1856 · Cited by 26
Advances in Research Related to MicroRNA for Diabetic Retinopathy
Luo, Y., & Li, C. (2024) · Journal of Diabetes Research · doi:10.1155/2024/8520489 · Cited by 22
“Locked nucleic acids (LNA) can form a complementary pairing with RNA, single-stranded DNA, and double-stranded DNA with higher a ffi nity [225, 226].”
BackgroundSite-Specific Chemical Labeling of Long RNA Molecules
Jahn, K., Olsen, E. M., Nielsen, M. M., Tørring, T., Mohammadzadegan, R., Andersen, E. S., Gothelf, K. V., & Kjems, J. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100422k · Cited by 21
Highly Rapid Amplification-Free and Quantitative DNA Imaging Assay
Klamp, T., Camps, M., Nieto, B., Guasch, F., Ranasinghe, R. T., Wiedemann, J., Petrášek, Z., Schwille, P., Klenerman, D., & Sauer, M. (2013) · Scientific Reports · doi:10.1038/srep01852 · Cited by 22
Improvement of a streptavidin-binding aptamer by LNA- and α-l-LNA-substitutions
Jørgensen, A. S., Hansen, L. H., Vester, B., & Wengel, J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.082 · Cited by 22
Self-citationTwo-dimensional LNA/DNA arrays: estimating the helicity of LNA/DNA hybrid duplex
Rinker, S. D., Liu, Y., & Yan, H. (2006) · Chemical Communications · doi:10.1039/b603872g · Cited by 21
MicroRNAs in diffuse large B-cell lymphoma
Ni, H., TONG, R., Zou, L., Song, G., & Cho, W. C. S. (2015) · Oncology Letters · doi:10.3892/ol.2015.4064 · Cited by 24
Nonviral siRNA delivery systems for pancreatic cancer therapy
Aghamiri, S., Raee, P., Talaei, S., Mohammadi‐Yeganeh, S., Bayat, S., Rezaee, D., Ghavidel, A. A., Teymour, A., Roshanzamiri, S., Farhadi, S., et al. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27869 · Cited by 23
“Besides their well‐developed surface chemistry, silica materials have several advantages including safety, biodegradability, and biocompatibility which make them suitable for efficient drug delivery platforms and siRNA carriers (Wang et al., 2015).”
BackgroundElectrochemical nucleic acid biosensors: from fabrication to application
Tan, A., Lim, C., Zou, S., Ma, Q., & Gao, Z. (2016) · Analytical Methods · doi:10.1039/c6ay01221c · Cited by 21
LNA nucleotides improve cleavage efficiency of singular and binary hammerhead ribozymes
Klitgaard, J. K., Lobedanz, S., Arar, K., Wengel, J., & Vester, B. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.06.045 · Cited by 21
Self-citationA 5′‐Cap for DNA Probes Binding RNA Target Strands
Egetenmeyer, S., & Richert, C. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201101828 · Cited by 19
Screening for Protein-DNA Interactions by Automatable DNA-Protein Interaction ELISA
Brand, L. H., Henneges, C., ssler, A. S. ⁄., Kolukisaoglu, H. Ü., Koch, G., Wallmeroth, N., Hecker, A., Thurow, K., Zell, A., Harter, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075177 · Cited by 23
“To increase oligonucleotide hybridization efficiency and to avoid the accidental introduction of sequences that are known to form Z-like DNA-conformations in vitro, we decided to use adenyl linkers of different length, which results in an asymmetric organization of the dsDNA-probes [48].”
MethodBacillus subtilis 6S-2 RNA serves as a template for short transcripts in vivo
Hoch, P. G., Schlereth, J., Lechner, M., & Hartmann, R. K. (2016) · RNA · doi:10.1261/rna.055616.115 · Cited by 20
“It binds to the housekeeping RNA polymerase (RNAP) holoenzyme by mimicking an open promoter structure (Wassarman 2002; Barrick et al. 2005).”
BackgroundPotential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
Allegra, A., Ettari, R., Innao, V., & Bitto, A. (2021) · Cells · doi:10.3390/cells10020448 · Cited by 23
Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
Romanò, R., & Bucci, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385285 · Cited by 23
“Locked-nucleic acid is a nucleic acid analog containing at least one locked-nucleic acid monomer with a bicyclic furanose unit locked in an RNA-mimicking sugar conformation that gives an improved affinity for target RNA (Vester and Wengel, 2004).”
BackgroundGu, X., Nguyen, M.-T., Overacre-Delgoffe, A. E., Seaton, S., & Schroeder, S. J. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp312154d · Cited by 21
Roussis, I. M., Guille, M., Myers, F. A., & Scarlett, G. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147967 · Cited by 20
Rapozzi, V., Cogoi, S., & Xodo, L. E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0006 · Cited by 24
“develops when a hematopoietic stem cell acquires the Philadelphia chromosome carrying the chimeric BCR/ABL oncogene resulting from a chromosomal translocation: t(9;22) (1, 2).”
BackgroundNucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects
Yao, Y., Yang, M., & Shi, S. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230202155414 · Cited by 20
Ostberg, C. O., Chase, D. M., Hayes, M. C., & Duda, J. J. (2018) · PeerJ · doi:10.7717/peerj.4496 · Cited by 25
Han, S., Scherer, L. J., Gethers, M., Salvador, A. M., Salah, M. B. H., Mancusi, R. A., Sagar, S., Hu, R., DeRogatis, J. M., Kuo, Y., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.12.039 · Cited by 19
Detection of MicroRNAs by Northern Blot
Martinho, C., & López-Gomollón, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2982-6_4 · Cited by 19
Maximizing Mismatch Discrimination by Surface-Tethered Locked Nucleic Acid Probes via Ionic Tuning
Mishra, S., Ghosh, S., & Mukhopadhyay, R. (2012) · Analytical Chemistry · doi:10.1021/ac3028382 · Cited by 19
Jackson, A., Jani, S., Davies‐Sala, C., Soler‐Bistué, A., Zorreguieta, Á., & Tolmasky, M. E. (2016) · Biology Methods and Protocols · doi:10.1093/biomethods/bpw001 · Cited by 19
Braendli-Baiocco, A., Festag, M., Erichsen, K. D., Persson, R., Mj, M., Fisker, N., Funk, J., Mohr, S., Constien, R., Ploix, C. C., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx025 · Cited by 21
Synthesis, Duplex Stabilization and Structural Properties of a Fluorinated Carbocyclic LNA Analogue
Seth, P. P., Pallan, P. S., Swayze, E. E., & Egli, M. (2012) · ChemBioChem · doi:10.1002/cbic.201200669 · Cited by 19
Holasová, Š., Mojžíšek, M., Bunček, M., Vokurková, D., Radilová, H., Šafářová, M., Červinka, M., & Haluza, R. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-2912-8 · Cited by 19
“Several methods have been tested to achieve better cytoplasm and nuclear delivery [12, 13].”
MethodShen, L., Johnson, T. L., Clugston, S. L., Huang, H., Butenhof, K. J., & Stanton, R. V. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200141j · Cited by 18
Zeng, Y., Koo, K. M., Shen, A., Hu, J., & Trau, M. (2020) · Small · doi:10.1002/smll.202006370 · Cited by 18
Djebbi, K., Xing, J., Weng, T., Bahri, M., Elaguech, M. A., Du, C., Shi, B., Hu, L., He, S., Liao, P., et al. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339778 · Cited by 18
Lait, L. A., Rutledge, L. R., Millen, A. L., & Wetmore, S. D. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp805547p · Cited by 18
Obika, S., Rahman, S. M. A., Song, B., Onoda, M., Koizumi, M., Morita, K., & Imanishi, T. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.013 · Cited by 18
Modified RNA triplexes: Thermodynamics, structure and biological potential
Szabat, M., Kierzek, E., & Kierzek, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-31387-5 · Cited by 21
Obika, S., Inohara, H., Hari, Y., & Imanishi, T. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.12.043 · Cited by 18
Advances in the pharmaceutical development of antibody-oligonucleotide conjugates
Li, M., An, H., Zhang, J., Li, W., Yu, C., & Wang, L. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107292 · Cited by 25
Kaurani, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052866 · Cited by 21
“Furthermore, studies have shown that LNA-containing anti-miRs exhibit increased solubility in water and culture media, making them more suitable for in vivo applications [136–138].”
BackgroundYan, Y., Yan, J. Y., Piao, X., Zhang, T., & Guan, Y. (2012) · Journal of Biosciences · doi:10.1007/s12038-012-9196-4 · Cited by 17
“These data demonstrate a consistency with previously reported results (Vester and Wengel 2004; Kaur et al. 2006).”
Rocha, C. S. J., Lundin, K. E., Behlke, M. A., Zain, R., Andaloussi, S. E., & Smith, C. I. E. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0631 · Cited by 19
“To increase target affinity, additional modifications such as 2 ¢ -OMe [6], LNA (with increased half-live in blood and thus potency, but also increased risk for off-target effects) [6,35,36], or ZEN (high target affinity but being less active in terms of ‘‘naked’’ uptake) [8,9] were included.”
Mitsuoka, Y., Yamamoto, T., Kugimiya, A., Waki, R., Wada, F., Tahara, S., Sawamura, M., Noda, M., Fujimura, Y., Kato, Y., et al. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b02417 · Cited by 17
Diercks, S., Gescher, C., Metfies, K., & Medlin, L. (2009) · Journal of Applied Phycology · doi:10.1007/s10811-008-9399-0 · Cited by 17
“or RNA, are obtainable commercially (Braasch and Corey 2001) and are not affected by nucleases (Vester and Wengel 2004).”
BackgroundEffect of Locked Nucleic Acid Modifications on the Thermal Stability of Noncanonical DNA Structure
Bhattacharyya, J., Maiti, S., Muhuri, S., Nakano, S., Miyoshi, D., & Sugimoto, N. (2011) · Biochemistry · doi:10.1021/bi200477g · Cited by 17
Novel insights regarding the role of noncoding RNAs in diabetes
Mačvanin, M., Gluvic, Z. M., Bajić, V., & Isenović, E. R. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.958 · Cited by 17
Effect of Thiazole Orange Doubly Labeled Thymidine on DNA Duplex Formation
Kimura, Y., Hanami, T., Tanaka, Y., de Hoon, M., Soma, T., Harbers, M., Lezhava, A., Hayashizaki, Y., & Usui, K. (2012) · Biochemistry · doi:10.1021/bi300293d · Cited by 16
Whole-mount in situ detection of microRNAs on Arabidopsis tissues using Zip Nucleic Acid probes
Begheldo, M., Ditengou, F. A., Cimoli, G., Trevisan, S., Quaggiotti, S., Nonis, A., Palme, K. J., & Ruperti, B. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.10.039 · Cited by 15
Synthesis and properties of novel l-isonucleoside modified oligonucleotides and siRNAs
Zhang, J., Chen, Y., Huang, Y., Jin, H., Qiao, R., Xing, L., Zhang, L., Yang, Z., & Zhang, L. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob26219c · Cited by 17
Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy
Marini, F., & Brandi, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147352 · Cited by 18
RNA-Seq for Plant Pathogenic Bacteria
Kimbrel, J. A., Di, Y., Cumbie, J. S., & Chang, J. H. (2011) · Genes · doi:10.3390/genes2040689 · Cited by 26
“LNAs are nucleotide analogs capable of complementary basepairing but with much higher thermal affinities allowing for the use of a higher temperature during depletion steps to increase the specificity of rRNA capture [41].”
Background
Metadata
- Authors
- Vester, B., & Wengel, J.
- Affiliations
- University of Southern Denmark (DK)
- Corresponding author
- Vester, Birte
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-10-01
- Volume
- 43
- Issue
- 42
- Pages
- 13233-13241
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2139273728
- Cited by
- 727
- References
- 57
- Citations by year
- 2026: 19 · 2025: 34 · 2024: 23 · 2023: 28 · 2022: 38 · 2021: 32 · 2020: 26 · 2019: 27 · 2018: 32 · 2017: 24 · 2016: 40 · 2015: 34 · 2014: 45 · 2013: 35 · 2012: 54
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- locked nucleic acid, LNA oligonucleotides, nucleic acid analogs, hybridization affinity, gene silencing, nucleic acid diagnostics, RNA mimics
- MeSH terms
- Endoribonucleases, Hydrolysis, Nucleic Acid Conformation, Nucleotides, Oligonucleotides, Ribose, Oligonucleotides, Antisense, RNA, Complementary, DNA, Complementary, Molecular Mimicry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.